Advances in psoriasis research: From pathogenesis to therapeutics

Dineshwar Sugumaran1, Audrey Chee Hui Yong2, Johnson Stanslas1

  • 1Pharmacotherapeutic Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.

Life Sciences
|August 17, 2024
PubMed

Insights

Psoriasis, a chronic inflammatory skin disease, involves complex immune pathways. This review highlights current research on its pathogenesis, signaling pathways, and novel therapeutic strategies for improved patient management.

Area of Science:

  • Dermatology and Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Psoriasis affects 2-3% of the global population as a chronic inflammatory skin condition.
  • Its pathogenesis is multifactorial, involving immune dysregulation, hyperproliferation, angiogenesis, and genetic/environmental factors.

Purpose of the Study:

  • To review the current understanding of psoriasis pathogenesis.
  • To highlight advancements in therapeutic agents and drug delivery strategies.
  • To identify future research opportunities for personalized interventions.

Main Methods:

  • Comprehensive literature review of psoriasis pathogenesis.
  • Analysis of signaling pathways (NF-κB, JAK-STAT, S1P, PDE-4, A3AR) involved in psoriasis.
  • Examination of preclinical models and technological advancements in psoriasis research.

Main Results:

  • Detailed overview of key signaling pathways implicated in psoriasis.
  • Discussion of approved and investigational molecules targeting these pathways.
  • Exploration of recent breakthroughs in therapeutic and drug delivery approaches.

Conclusions:

  • An extensive understanding of psoriasis pathogenesis, signaling pathways, and therapeutic agents is crucial for developing efficient treatments.
  • Technological advancements and novel drug delivery strategies offer opportunities for improved psoriasis management.
  • This review provides a foundation for future research into personalized psoriasis interventions.

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
964
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
529
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K